AI in Oncology Paris 22-23 June 2026

Editorial

Following the success of the first edition, in Paris in June 2025, the second edition of the AI in Oncology Conference by PRISM Institute took place on June 22–23, 2026, at the Novotel Paris Tour Eiffel.

This international conference once again confirmed the growing interest in the application of artificial intelligence to cancer care and research, bringing together 240 participants from diverse backgrounds, including clinicians, researchers, data scientists, and industry experts.

Building on the foundations established in 2025, the 2026 edition expanded its scope to showcase the latest advances and real-world applications of AI that are transforming oncology. Participants explored cutting-edge topics spanning radiology, digital pathology, generative AI, multiomics, precision oncology, clinical decision support, and emerging AI-driven innovations.

More than a scientific meeting, the conference fostered a highly interactive environment that encouraged lively discussions, knowledge sharing, and meaningful exchanges throughout the two days. The quality of the debates, the diversity of perspectives, and the strong engagement of participants created numerous opportunities for networking and future collaborations, reinforcing the conference's role as a key forum for the AI and oncology community.

We would like to warmly thank all speakers, partners, sponsors, and participants for contributing to the remarkable success of this second edition. We look forward to continuing this collective journey at the intersection of artificial intelligence and oncology in the years to come.